Trulieve Cannabis (TRLV) Operating Expenses (2020 - 2026)

Trulieve Cannabis has reported Operating Expenses for 7 years, with the latest figure at $532.8 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 308.94% year-over-year to $532.8 million in Q2 2026; TTM through Jun 2026 was $954.7 million, a 49.5% increase from a year earlier, with the FY2025 full-year figure at $567.7 million, down 8.14% from the prior year.
• Operating Expenses was $532.8 million for Q2 2026 at Trulieve Cannabis, up from $134.4 million in the prior quarter.
• The five-year high for Operating Expenses was $532.8 million in Q2 2026, with the low at $119.6 million in Q3 2023.
• Average Operating Expenses over 5 years is $183.6 million, with a median of $145.9 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: Operating Expenses plunged 69.53% in 2024, then soared 308.94% in 2026.
• Over 5 years, Operating Expenses stood at $151.9 million in 2022, then fell by 17.93% to $124.7 million in 2023, then jumped by 48.96% to $185.7 million in 2024, then slipped by 13.91% to $159.9 million in 2025, then surged by 233.28% to $532.8 million in 2026.
• The last three Operating Expenses figures came in at $532.8 million (Q2 2026), $134.4 million (Q1 2026), and $159.9 million (Q4 2025), per Business Quant data.